Target intelligence / Profile preview

Nociceptive afferent neuron (None (commonly "nociceptor" as a shortened form, but not a formal abbreviation))

Target
None (commonly "nociceptor" as a shortened form, but not a formal abbreviation)
Molecular classification
Other (sensory neuron/fiber), Ion channel (notably TRP channels and various voltage-gated Na(+), K(+), Ca(2+) channels expressed in nociceptors)
01

Overview

Nociceptive afferent neurons are sensory nerve fibers responsible for detecting and transmitting signals from damaged tissue or threats of damage to the central nervous system, initiating pain sensation[1][3][6]. There are several classes of such fibers—primarily the Aδ (thinly myelinated, fast-conducting) and C fibers (unmyelinated, slow-conducting)—that differ in their conduction velocities and stimulus sensitivities[1][5][3]. These neurons utilize specific ion channels (e.g., various TRP channels, voltage-gated sodium channels), and their subpopulations can be further classified by neuropeptide expression (peptidergic vs. non-peptidergic)[3][5]. They play crucial roles not only in pain perception but also in neurogenic inflammation and modulation of immune responses[3]. Drugs targeting these neurons (e.g., sodium channel blockers, TRPV1 antagonists, opioids) aim to reduce pain transmission, but therapeutic manipulation must balance analgesia with avoidance of sensory loss and chronic pain conversion[4][3]. Summary of interpretation and limitations: "Nociceptive nerve afferents" is not a molecular target like a receptor, transporter, or enzyme, but rather refers to a population of neurons. For structured databases, nociceptor subtypes or the specific ion channels/receptors they express (e.g., TRPV1, Nav1.7) would represent conventional molecular targets.

Other names
nociceptorspain-sensing neuronssensory afferent pain fibersprimary afferent nociceptorspain fibers
02

Mechanism of action

Blocking ion channels involved in signal transduction (e.g., voltage-gated sodium channels, TRP channels) Inhibiting neurotransmitter release (e.g., substance P, CGRP) to reduce neurogenic inflammation and pain signaling Modulation of receptor activity on nociceptors

03

Biological functions

Pain detection and transmission (nociception)Signal transduction of mechanical, thermal, and chemical noxious stimuliNeurogenic inflammation (release of neuropeptides)Coordination of immune cell responses
04

Disease associations

InflammationNeuropathic painChronic pain disorders (e.g., fibromyalgia, arthritis, peripheral neuropathy)Peripheral sensitization (pain hypersensitivity and chronic pain)Other (interactions with immune system in infection)
05

Safety considerations

Risks of sensory loss or numbness with excessive inhibitionPotential for central sensitization and chronic pain if manipulation is incomplete or inappropriateOff-target effects impacting other neuronal functions
06

Interacting drugs

Local anesthetics (e.g., lidocaine)

3 more in the full profile.

07

Biomarkers

Expression of voltage-gated sodium channels (Nav1.7, Nav1.8)TRP channel subtype expression (e.g., TRPV1, TRPM8)Neuropeptides (substance P, CGRP)IB4 binding for non-peptidergic population, CGRP expression for peptidergic

Beyond the preview

Go deeper on Nociceptive afferent neuron (None (commonly "nociceptor" as a shortened form, but not a formal abbreviation)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nociceptive afferent neuron (None (commonly "nociceptor" as a shortened form, but not a formal abbreviation)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call